In the non-metastatic NSCLC, PD-L1 expression on CAFs is reversibly regulated by IFN-γ from activated lymphocytes and suggests the induction of anti-tumor immune responses, contributing to a better prognosis after surgery. This evidence concerns the gene CD274 and non-small cell lung carcinoma.